A novel lamin A/C mutation in a Dutch family with premature atherosclerosis

Atherosclerosis

Volumn 229, Issue 1, 2013, Pages 169-173

  Weterings, A A W ^a   van Rijsingen, I A W ^a   Plomp, A S ^a   Zwinderman, A H ^a   Lekanne Deprez, R H ^a   Mannens, M M ^a   van den Bergh Weerman, M A ^a   van der Wal, A C ^a   Pinto Sietsma, S J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

FPLD; Lipodystrophy; LMNA; Premature atherosclerosis

Indexed keywords

LAMIN A; LAMIN C;

ADULT; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CLINICAL ARTICLE; CLINICAL EVALUATION; DIABETES MELLITUS; ELECTRON MICROSCOPY; FATHER; FEMALE; GENE MUTATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIBLING;

ADULT; AGE OF ONSET; ATHEROSCLEROSIS; DERMIS; DIABETES MELLITUS; FAMILY HEALTH; FATAL OUTCOME; FATTY LIVER; FEMALE; FIBROBLASTS; HUMANS; LAMIN TYPE A; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NETHERLANDS; PEDIGREE; POINT MUTATION; YOUNG ADULT;

EID: 84879410163     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.016     Document Type: Article

References (20)

1. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997 May 3, 349(9061):1269-1276.
2. Allender S, Scarborough P, Peto V, etal. European cardiovascular disease statistics. 2008 edition:103-5.
3. Pyörälä K., De Backer G., Graham I., et al. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994 Oct, 110(2):121-161.
4. De Bacquer D., De Backer G., Kornitzer M., Blackburn H. Parental history of premature coronary heart disease mortality and signs of ischemia on the resting electrocardiogram. JAm Coll Cardiol 1999 May, 33(6):1491-1498.
5. The oxford centre for diabetes, endocrinology and metabolism. HOMA calculator. (URL: ). http://www.dtu.ox.ac.uk/homacalculator/index.php.
6. Van Spaendonck-Zwarts K.Y., van Rijsingen I.A., van den Berg M.P., et al. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience. Eur J Heart Fail 2013 Jan 24, [Epub ahead of print].
7. Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA. (URL: ). [accessed 05.12]. http://evs.gs.washington.edu/EVS/.
8. Vigouroux C., Auclair M., Dubosclard E., et al. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. JCell Sci 2001, 114:4459-4468.
9. Kandert S., Lüke Y., Kleinhenz T., et al. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells. Hum Mol Genet 2007 Dec 1, 16(23):2944-2959.
10. Kandert S., Wehnert M., Müller C.R., Buendia B., Dabauvalle M.C., et al. Impaired nuclear functions lead to increased senescence and inefficient differentiation in human myoblasts with a dominant p.R545C mutation in the LMNA gene. Eur J Cell Biol 2009 Oct, 88(10):593-608. [Epub 2009 Jul8].
11. Hegele R.A., Cao H., Liu D.M., et al. Sequencing of the re-annotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet 2006, 79:383-389.
12. Simha V., Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009, 20:300-308.
13. Worman H.J. Nuclear lamins and laminopathies. JPathol 2012 Jan, 226(2):316-325. [Epub 2011 Nov 14]. 10.1002/path.2999.
14. Al-Shali Khalid Z., Hegele Robert A. Laminopathies and atherosclerosis. Atheroscler Thromb Vasc Biol 2004, 24:1591-1595.
15. Bidault G., Vatier C., Capeau J., Vigouroux C., Béréziat V. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations. Biochem Soc Trans 2011, 39. part 6.
16. Hegele Premature atherosclerosis associated with monogenic insulin resistance. Circulation 2001, 103:2225-2229.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul, 28(7):412-419.
18. Garg A., Speckman R.A., Bowcock A.M. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med 2002, 112:549-555.
19. Caux F., Dubosclard E., Lascols O. Anew clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermid papules, liver steatosis, and cardiomyopathy. JClin Endocrinol Metab 2003, 88:1006-1013.
20. van der Kooi A.J., Bonne G., Eymard B. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 2002, 59:620.